Latest Investment News

Zoono Group Limited is raising nearly $1.8 million through a non-renounceable rights issue to fund its supermarket shelf-life extension project in Asia and reduce related party debt.

Galan Lithium has locked in a A$20 million equity placement from strategic partner Clean Elements, providing crucial funding to complete Phase 1 construction of its Hombre Muerto West lithium project in Argentina, targeting first production in early 2026.

Motio Ltd has reported a record-breaking Q4 revenue of approximately $2.6 million, marking a 35% year-on-year increase, alongside significant debt reduction and a strong cash position heading into FY26.

Osmond Resources has reported strong assay results from Zone 2 of its Orion EU Critical Minerals Project in Southern Spain, revealing high-grade rutile and zircon mineralisation. The company is now prioritising a maiden drilling program to validate these findings and advance project development.

Lendlease has completed the $235 million sale of its 70% stake in Capella Capital to Sojitz Corporation, advancing its broader $2.5 billion capital recycling strategy aimed at simplifying the group and focusing on core Australian operations.

Transurban Group has announced a 33-cent ordinary dividend for the half-year ending June 2025, offering shareholders a fully franked, no-discount dividend reinvestment plan.

Growthpoint Properties Australia has announced a final distribution of 9.1 cents per security for FY25, maintaining its full-year guidance and sustainability commitments.

Minbos Resources has approved over A$800,000 in long lead item orders to advance Stage 2 construction of its Subantando Fertilizer Plant in Angola, supported by sovereign and development financing.

Mach7 Technologies has expanded its partnership with a major US radiology marketplace, signing a five-year licence amendment worth A$5 million that extends the contract by three years and adds significant value.

Zenith Minerals has opened a fully underwritten $3.5 million entitlement offer, inviting shareholders to subscribe for new shares with free attaching options, aiming to bolster its gold and lithium exploration projects.

Bioxyne Limited has upgraded its FY2025 revenue guidance to approximately $28 million, driven by strong domestic performance and significant progress in European and UK markets. The company also advances its psychedelic medicines pipeline, positioning itself for sustained growth.

Symal Group is poised to exceed its FY2025 EBITDA forecast, driven by strong project execution and a robust pipeline of contracts and acquisitions.